Scott M. Giacobello
CIK 1754154 · CHIEF FINANCIAL OFFICER · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.39M
Companies
3
Total Filings
23
Lifetime Open-Market Net
-$1.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | CHIEF FINANCIAL OFFICER | 333,489 | $4.16 | $1.39M | -$890.6K | 5 | 2026-05-18 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | CHIEF FINANCIAL OFFICER | 26,750 | $2.05 | $54.8K | -$6.6K | 6 | 2025-03-03 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | Chief Financial Officer | 161,120 | $218.96 | $35.28M | -$131.3K | 11 | 2021-03-04 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-21 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +3,912 | -$61.3K | EDGAR |
| 2019-03-05 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-28 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +5,172 | -$65.1K | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.